Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
enGene Therapeutics Inc. is a clinical-stage biotechnology company mainstreaming non-viral genetic medicine through the delivery of therapeutics to mucosal tissues and other organs. The Company's lead program is detalimogene voraplasmid (also known as detalimogene) for patients with non-muscle invasive bladder cancer (NMIBC), a disease with a high clinical burden. Detalimogene is being evaluated in the ongoing multi-cohort LEGEND Phase 2 trial, which includes a pivotal cohort studying detalimogene at high-risk, Bacillus Calmette-Guerin (BCG)-unresponsive patients with carcinoma in situ (CIS) with or without concomitant papillary disease. Detalimogene is being developed using its proprietary Dually Derivatized Oligochitosan (DDX) platform, which enables penetration of mucosal tissues and delivery of a wide range of sizes and types of cargo, including Deoxyribonucleic acid (DNA) and various forms of Ribonucleic acid (RNA).
Find out what a historical investment in enGene Therapeuctics Inc would be worth today using our ENGN stock calculator.
Buying ENGN shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in enGene Therapeuctics Inc in minutes.
Sign up with some I.D. and zero paperwork
Add funds to your account
Make your first investment in ENGN
What is the ticker symbol of enGene Therapeuctics Inc?
The ticker symbol for enGene Therapeuctics Inc is ENGN.
How much is one share of ENGN?
One share of ENGN is valued at $1.76 as of 20 November 2026.
What is the market capitalisation of enGene Therapeuctics Inc ENGN?
As of 20 November 2026 enGene Therapeuctics Inc has a market cap of $123.98M.
What is the 52-week high for enGene Therapeuctics Inc stock?
The enGene Therapeuctics Inc 52-week high stock price is $12.25.
What is the 52-week low for enGene Therapeuctics Inc stock?
The enGene Therapeuctics Inc 52-week low stock price is $1.40.
Can I buy ENGN shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy ENGN shares and over 13,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in ENGN on Stake
Buy ENGN from US$3 brokerage
Invest in 11,000+ U.S. stocks and ETFs
Own a slice of ENGN from only US$10 with fractional shares